| Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia K Dharmarajan, AF Hsieh, Z Lin, H Bueno, JS Ross, LI Horwitz, ... Jama 309 (4), 355-363, 2013 | 1182 | 2013 |
| Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study K Dharmarajan, AF Hsieh, VT Kulkarni, Z Lin, JS Ross, LI Horwitz, N Kim, ... bmj 350, 2015 | 239 | 2015 |
| National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998–2010 J Chen, AFC Hsieh, K Dharmarajan, FA Masoudi, HM Krumholz Circulation 128 (24), 2577-2584, 2013 | 204 | 2013 |
| Readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia among young and middle-aged adults: a retrospective observational cohort study I Ranasinghe, Y Wang, K Dharmarajan, AF Hsieh, SM Bernheim, ... PLoS medicine 11 (9), e1001737, 2014 | 124 | 2014 |
| Hospital readmission performance and patterns of readmission: retrospective cohort study of Medicare admissions K Dharmarajan, AF Hsieh, Z Lin, H Bueno, JS Ross, LI Horwitz, ... Bmj 347, 2013 | 114 | 2013 |
| Sex differences in the rate, timing, and principal diagnoses of 30-day readmissions in younger patients with acute myocardial infarction RP Dreyer, I Ranasinghe, Y Wang, K Dharmarajan, K Murugiah, SV Nuti, ... Circulation 132 (3), 158-166, 2015 | 99 | 2015 |
| The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study M Davidson, M Stevenson, A Hsieh, Z Ahmad, JR van Lennep, ... Journal of clinical lipidology 12 (4), 898-907. e2, 2018 | 56 | 2018 |
| Trajectories of risk for specific readmission diagnoses after hospitalization for heart failure, acute myocardial infarction, or pneumonia HM Krumholz, A Hsieh, RP Dreyer, J Welsh, NR Desai, K Dharmarajan PloS one 11 (10), e0160492, 2016 | 53 | 2016 |
| The effect of volanesorsen treatment on the burden associated with familial chylomicronemia syndrome: the results of the ReFOCUS study M Arca, A Hsieh, H Soran, P Rosenblit, L O’Dea, M Stevenson Expert Review of Cardiovascular Therapy 16 (7), 537-546, 2018 | 46 | 2018 |
| Describing the performance of US hospitals by applying big data analytics NS Downing, A Cloninger, AK Venkatesh, A Hsieh, EE Drye, RR Coifman, ... PLoS One 12 (6), e0179603, 2017 | 30 | 2017 |
| Sex differences in trajectories of risk after rehospitalization for heart failure, acute myocardial infarction, or pneumonia RP Dreyer, K Dharmarajan, AF Hsieh, J Welsh, L Qin, HM Krumholz Circulation: Cardiovascular Quality and Outcomes 10 (5), e003271, 2017 | 28 | 2017 |
| Relationship between age and trajectories of rehospitalization risk in older adults K Dharmarajan, A Hsieh, RP Dreyer, J Welsh, L Qin, HM Krumholz Journal of the American Geriatrics Society 65 (2), 421-426, 2017 | 24 | 2017 |
| Treatment with Volanesorsen (VLN) reduced triglycerides and pancreatitis in patients with FCS and sHTG vs placebo: results of the APPROACH and COMPASS A Gelrud, A Digenio, V Alexander, K Williams, A Hsieh, I Gouni-Berthold, ... Journal of Clinical Lipidology 12 (2), 537, 2018 | 22 | 2018 |
| Variation in and hospital characteristics associated with the value of care for Medicare beneficiaries with acute myocardial infarction, heart failure, and pneumonia NR Desai, LS Ott, EJ George, X Xu, N Kim, S Zhou, A Hsieh, SV Nuti, ... JAMA Network Open 1 (6), e183519-e183519, 2018 | 14 | 2018 |
| Evaluating the impact of peer support and connection on the quality of life of patients with familial chylomicronemia syndrome V Salvatore, A Gilstrap, KR Williams, S Thorat, M Stevenson, ... Expert Opinion on Orphan Drugs 6 (8), 497-505, 2018 | 6 | 2018 |
| Real-world (RW) characteristics, treatment (tx) patterns, and overall survival (OS) in US patients (pts) with metastatic breast cancer (mBC) and CNS metastases (CNS mets). A Shewade, AFC Hsieh, A Mani, NJA Al-Sakaff, T Sanglier, MD Taylor, ... Journal of Clinical Oncology 36 (15_suppl), 1037-1037, 2018 | 6 | 2018 |
| Comparative effectiveness of first-line nab-paclitaxel versus paclitaxel monotherapy in triple-negative breast cancer P Luhn, SY Chui, AFC Hsieh, J Yi, A Mecke, PS Bajaj, W Hasnain, ... Journal of Comparative Effectiveness Research 8 (14), 1173-1185, 2019 | 5 | 2019 |
| Comparative effectiveness of nab-paclitaxel vs. paclitaxel monotherapy as first-line (1L) treatment of metastatic triple-negative breast cancer (mTNBC) in US clinical practice T Luhn, S Chui, A Hsieh, J Yi, A Mecke, P Bajaj, W Hasnain, A Falgas, ... Annals of Oncology 29, viii101, 2018 | 2 | 2018 |
| Treatment with volanesorsen (VLN) reduced triglycerides and pancreatitis in patients with familial chylomicronemia syndrome (FCS) and severe hypertriglyceridemia (sHTG) vs … D Blom, S Freedman, A Gelrud, A Digenio, V Alexander, K Williams, ... Pancreatology 18 (4), S101, 2018 | 2 | 2018 |
| The burden of illness and psychosocial consequences of living with familial chylomicronemia syndrome (FCS): patient and caregiver perspectives A Brown, J Ross, A Gilstrap, A Hsieh, K Williams, A Gelrud CLINICAL CARDIOLOGY 39, 15-15, 2016 | 2 | 2016 |
Harlan KrumholzYale UniversityVerified email at yale.edu
